Our transcriptomic results provide evidence of the relevance of DNAH5 to asthma, given that its gene expression levels were decreased in bronchial epithelium of patients with asthma versus controls and in airway smooth muscle cells after budesonide exposure. This evidence concerns the gene DNAH5 and asthma.